Agenus Inc. (AGEN) Q3 2024 Earnings Call

Investor webinar replay

Watch the replay and follow the connected company analysis, news, and investor updates for Agenus Inc..

Watch the replay

Replay transcript excerpt

WEBVTT 00:00:01.775 -- 00:00:07.379 Good morning and welcome to Agenis' third quarter 2024 conference call and webcast. 00:00:07.379 -- 00:00:11.782 All participants will be in a listen-only mode until the question and answer session. 00:00:11.782 -- 00:00:14.704 Please note, this event is being recorded. 00:00:14.704 -- 00:00:18.566 If anyone has any objections, you may disconnect at this time. 00:00:18.566 -- 00:00:24.330 I would now like to turn the conference over to Alexa Buffa from Agenis Corporate Communications. 00:00:24.330 -- 00:00:27.511 Alexa, please go ahead. 00:00:27.612 -- 00:00:30.947 Thank you, Operator, and thank you all for joining us today. 00:00:30.947 -- 00:00:35.569 Today's call is being webcast and will be available on our website for reply. 00:00:35.569 -- 00:00:39.772 I'd like to remind you that this call will include forward-looking statements, including 00:00:39.772 -- 00:00:44.875 statements regarding our clinical development, regulatory and commercial plans, and 00:00:44.875 -- 00:00:50.217 timelines, as well as timelines for data releases and partnership opportunities, 00:00:50.217 -- 00:00:55.220 among other updates. These statements are subject to risks and uncertainties, and 00:00:55.220 -- 00:01:00.363 we refer you to our SEC filings available on our website for more details on these 00:01:00.363 -- 00:01:01.926 risks. 00:01:01.926 -- 00:01:07.068 Joining me today are Dr. Garrow Arman, Chairman and Chief Executive Officer, Dr. 00:01:07.068 -- 00:01:12.309 Robin Taylor, Chief Commercial Officer, and Christine Klaskin, Vice President 00:01:12.309 -- 00:01:17.591 of Finance. Dr. Stephen O'Day, Chief Medical Officer, will be participating in the question 00:01:17.591 -- 00:01:22.533 and answer session. Now I'd like to turn the call over...